Skip to main content
The BMJ logoLink to The BMJ
. 1998 May 2;316(7141):1353–1354. doi: 10.1136/bmj.316.7141.1353

Is cardiothoracic ratio in healthy middle aged men an independent predictor of coronary heart disease mortality? Whitehall study 25 year follow up

Harry Hemingway a, Martin Shipley b, David Christie c, Michael Marmot b
PMCID: PMC28534  PMID: 9563985

Aetiological studies of myocardial ischaemia have tended to concentrate on factors which influence atherothrombotic processes in the coronary arteries rather than myocardial pathophysiology.1 The commonest clinical measure of heart size—cardiothoracic ratio—was included in the original Whitehall study of healthy middle aged civil servants. Cardiothoracic ratio is associated with left ventricular mass2 and left ventricular systolic function; since left ventricular mass determined by echocardiography has been shown to predict coronary heart disease in elderly people,1 we hypothesised that increased cardiothoracic ratio would independently predict mortality from coronary heart disease. Unlike previous studies3 we did not include mortality from stroke since it may be related to heart size through different pathophysiological mechanisms.

Subjects, methods, and results

We studied the 1203 male British civil servants aged 40-69 years who participated in the original Whitehall study and were randomly selected (by random number tables) for measurement of cardiothoracic ratio from 100 mm chest radiographs. The rate ratio for all cause mortality among those in the random sample compared with those not in the sample was 1.01 (95% confidence interval 0.93 to 1.11) making a serious selection bias unlikely. Details of the standardised methods of risk factor, electrocardiographic and radiographic measurements and their quality control have been reported.4,5 Cardiothoracic ratio was calculated as the ratio of the maximal transverse diameter of the cardiac silhouette to the distance between the internal margins of the ribs at the level of the right hemidiaphragm. In all, 1191 (99%) of the subjects were flagged at the NHS Central Registry and there were 534 deaths over 25 years, 196 of which were due to coronary heart disease (ICD-8 codes 410-414). Adjusted mortality hazard ratios and their confidence intervals were estimated by Cox’s proportional hazards regression models.

The table shows the extent to which cardiothoracic ratio affects the risk of death from all and coronary causes independently of potential confounders. After age, blood pressure, heart rate, total cholesterol concentration, smoking, prevalent symptoms of coronary heart disease, and electrocardiographic evidence of ischaemia were adjusted for, men with a cardiothoracic ratio in the highest fifth of the distribution had a hazard ratio of 1.65 (95% confidence interval 1.01 to 2.70) for coronary heart disease mortality compared with men with a cardiothoracic ratio in the lowest fifth. When men with a ratio ⩾0.5 were excluded, the top fifth (⩾0.47 and <0.5) was associated with an increased risk of coronary death of 1.67 (0.99 to 2.82) after age and blood pressure were adjusted for.

Comment

The cardiothoracic ratio in a healthy middle aged population predicted coronary mortality over 25 years independent of blood pressure and other risk factors. A ratio of ⩾0.5 has by convention been defined as a threshold of pathological enlargement. In our healthy population of civil servants a ratio of 0.47 to <0.5 was associated with increased risk of death from coronary heart disease, questioning this convention. The results of recently established population based echocardiographic studies are therefore awaited to establish the relative contribution of left ventricular mass and left ventricular systolic dysfunction in predicting coronary heart disease among healthy middle aged subjects. Until then the Whitehall study offers the advantage of a prolonged follow up.

Does lowering cardiothoracic ratio reduce the risk of coronary heart disease? Among hypertensive patients, drug treatment and exercise may reduce cardiothoracic ratio. However, further studies are required to investigate whether such effects lead to a reduction in subsequent coronary heart disease events and therefore constitute a worthwhile therapeutic goal. In the meantime the prognostic information provided by the cardiothoracic ratio should be considered in risk stratification of healthy middle aged men.

Table.

Adjusted hazard ratios (95% confidence intervals) for the effect of cardiothoracic ratio on all cause and coronary heart disease mortality

Cardiothoracic ratio (fifths) All causes (534 deaths)
Coronary heart disease (196 deaths)
Adjusted for age Adjusted for age and blood pressure* Fully adjusted Adjusted for age Adjusted for age and blood pressure* Fully adjusted
<0.4 1.0 1.0 1.0 1.0 1.0 1.0
0.4-0.439 1.07 (0.80 to 1.42) 1.08 (0.80 to 1.45) 1.08 (0.80 to 1.46) 1.15 (0.69 to 1.92) 1.04 (0.62 to 1.75) 1.02 (0.61 to 1.73)
0.44-0.449 0.96 (0.72 to 1.28) 0.94 (0.69 to 1.27) 0.98 (0.72 to 1.34) 1.11 (0.67 to 1.87) 1.03 (0.61 to 1.74) 1.02 (0.60 to 1.74)
0.45-0.469 0.96 (0.72 to 1.28) 0.93 (0.69 to 1.26) 1.02 (0.75 to 1.38) 1.45 (0.89 to 2.37) 1.32 (0.81 to 2.16) 1.33 (0.81 to 2.20)
⩾0.47 1.38 (1.05 to 1.82) 1.27 (0.95 to 1.70) 1.28 (0.95 to 1.73) 2.15 (1.35 to 3.44) 1.84 (1.14 to 2.97) 1.65 (1.01 to 2.70)
*

Adjusted for systolic pressure and diastolic pressure.  

Adjusted for age, systolic blood pressure, diastolic blood pressure, heart rate, total cholesterol concentration, smoking habit, Rose angina, and electrocardiographic evidence of ischaemia (Minnesota codes: 1-1 to 1-3, 4-1 to 4-4, 5-1 to 5-3, and 7-1). 

Footnotes

Funding: MM is supported by an Medical Research Council research professorship. MS is supported by the British Heart Foundation.

Conflict of interest: None.

References

  • 1.Chambers J. Left ventricular hypertrophy: an underappreciated coronary risk factor. BMJ. 1995;311:273–274. doi: 10.1136/bmj.311.7000.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Davis JL, Murphy ML, Blue LR, Ferris EJ. A comparison of objective measurements on the chest roentgenogram as screening tests for right or left ventricular hypertrophy. Am J Cardiol. 1986;58:658–660. doi: 10.1016/0002-9149(86)90300-0. [DOI] [PubMed] [Google Scholar]
  • 3.Rautaharju PM, Lacroix AZ, Savage DD, Haynes SG, Madans JH, Wolf HK, et al. Electrocardiographic estimate of left ventricular mass versus radiographic cardiac size and the risk of cardiovascular disease mortality in the epidemiologic follow-up study of the first national health and nutrition examination survey. Am J Cardiol. 1988;62:59–66. doi: 10.1016/0002-9149(88)91365-3. [DOI] [PubMed] [Google Scholar]
  • 4.Reid DD, Brett GZ, Hamilton PJS, Jarrett RJ, Keen H, Rose G. Cardiorespiratory disease and diabetes among middle aged male civil servants. Lancet. 1974;i:469–473. doi: 10.1016/s0140-6736(74)92783-4. [DOI] [PubMed] [Google Scholar]
  • 5.Christie D. Physical correlates of radiologic heart volume. Acta Radiol Diag. 1978;19:732–736. doi: 10.1177/028418517801900503. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES